StockData
CytoDyn Inc. logo

CytoDyn Inc. (CYDY) stock

CYDYOTCPharmaceutical PreparationsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 14, 2026Score 4/30
$0.25+0.02 (+9.53%)

Close on Oct 19, 2026Market cap $345.56MP/E –Yield –

CytoDyn r&d expenses

Research and development expenses are spending on new products and technology.

CytoDyn's R&D Expenses for the twelve months ending May 31, 2024 was $7.24M. For fiscal 2024 it was $7.24M, up 175.1% from the year before. Over ten years it grew 6.2% a year on average. The highest annual figure on record is $53.40M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024May 31, 2024$7.24M+175.1%
FY2023May 31, 2023$2.63M-90.3%
FY2022May 31, 2022$27.04M-49.4%
FY2021May 31, 2021$53.40M+1.4%
FY2020May 31, 2020$52.64M+23.9%
FY2019May 31, 2019$42.49M+11.2%
FY2018May 31, 2018$38.22M+89.2%
FY2017May 31, 2017$20.21M+47.1%
FY2016May 31, 2016$13.73M-9.4%
FY2015May 31, 2015$15.16M+280.7%
FY2014May 31, 2014$3.98M+542.3%
FY2013May 31, 2013$619.84K+16.9%
FY2012May 31, 2012$530.03K+10.2%
FY2011May 31, 2011$480.77K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2024CQ2 2024May 31, 2024$3.60M+2525.5%
Q3 FY2024CQ1 2024Feb 29, 2024$650.00K+12.8%
Q2 FY2024CQ4 2023Nov 30, 2023$1.08M-73.1%
Q1 FY2024CQ3 2023Aug 31, 2023$1.91M-46.4%
Q2 FY2023CQ4 2022Nov 30, 2022$137.00K-98.2%
Q1 FY2023CQ3 2022Aug 31, 2022$576.00K-95.2%
Q4 FY2022CQ2 2022May 31, 2022$4.01M-57.1%
Q3 FY2022CQ1 2022Feb 28, 2022$3.57M-71.0%
Q2 FY2022CQ4 2021Nov 30, 2021$7.45M-54.7%
Q1 FY2022CQ3 2021Aug 31, 2021$12.02M-20.9%
Q4 FY2021CQ2 2021May 31, 2021$9.34M-53.2%
Q3 FY2021CQ1 2021Feb 28, 2021$12.32M-18.4%
Q2 FY2021CQ4 2020Nov 30, 2020$16.45M+92.9%
Q1 FY2021CQ3 2020Aug 31, 2020$15.19M+67.7%
Q4 FY2020CQ2 2020May 31, 2020$19.95M+116.9%
Q3 FY2020CQ1 2020Feb 29, 2020$15.11M+67.5%
Q2 FY2020CQ4 2019Nov 30, 2019$8.53M-33.7%
Q1 FY2020CQ3 2019Aug 31, 2019$9.06M-20.6%
Q4 FY2019CQ2 2019May 31, 2019$9.20M+3.1%
Q3 FY2019CQ1 2019Feb 28, 2019$9.02M-25.3%
Q2 FY2019CQ4 2018Nov 30, 2018$12.87M+41.8%
Q1 FY2019CQ3 2018Aug 31, 2018$11.40M+39.9%
Q4 FY2018CQ2 2018May 31, 2018$8.92M+59.2%
Q3 FY2018CQ1 2018Feb 28, 2018$12.08M+84.8%
Q2 FY2018CQ4 2017Nov 30, 2017$9.08M+107.1%
Q1 FY2018CQ3 2017Aug 31, 2017$8.15M+121.1%
Q4 FY2017CQ2 2017May 31, 2017$5.60M–
Q3 FY2017CQ1 2017Feb 28, 2017$6.53M–
Q2 FY2017CQ4 2016Nov 30, 2016$4.38M–
Q1 FY2017CQ3 2016Aug 31, 2016$3.69M–

More CytoDyn figures

See a number that looks wrong?